NasdaqGS - Delayed Quote USD

InMode Ltd. (INMD)

17.36 -0.01 (-0.06%)
At close: April 24 at 4:00 PM EDT
17.30 -0.06 (-0.35%)
After hours: April 24 at 7:44 PM EDT

Key Executives

Amounts are as of December 31, 2023 and compensation values are for the last fiscal year ending on that date. Pay is salary, bonuses, etc. Exercised is the value of options exercised during the fiscal year. Currency in USD.
NameTitlePayExercisedYear Born
Mr. Yair Malca Chief Financial Officer 581k -- 1978
Ms. Nava Tal-Launer Chief Information Officer 185k -- --
Mr. Shakil Lakhani President of North America 3.49M -- 1983
Mr. Moshe Mizrahy Chairman & CEO 216k -- 1953
Mr. Alon Yaari Vice President of Operations 281k -- --
Dr. Michael Kreindel CTO & Director 221k -- 1968
Dr. Spero Theodorou M.D. Chief Medical Officer 1.84M -- 1972

InMode Ltd.

Tavor Building
Sha’ar Yokneam PO Box 533
Yokne'am, 2069206
Israel
972 4 909 6313 https://www.inmodemd.com
Sector: 
Healthcare
Industry: 
Medical Devices
Full Time Employees: 
581

Description

InMode Ltd. designs, develops, manufactures, and markets minimally invasive aesthetic medical products based on its proprietary radiofrequency assisted lipolysis and deep subdermal fractional radiofrequency technologies in the United States and internationally. The company offers minimally invasive aesthetic medical products for various procedures, such as liposuction with simultaneous skin tightening, body and face contouring, and ablative skin rejuvenation treatments, as well as for use in women's health conditions and procedures. It also designs, develops, manufactures, and markets non-invasive medical aesthetic products that target an array of procedures, including permanent hair reduction, facial skin rejuvenation, wrinkle reduction, cellulite treatment, skin appearance and texture, and superficial benign vascular and pigmented lesions, as well as hands-free medical aesthetic products that target a range of procedures, such as skin tightening, fat reduction, and muscle stimulation. The company was formerly known as Invasix Ltd. and changed its name to InMode Ltd. in November 2017. InMode Ltd. was incorporated in 2008 and is headquartered in Yokneam, Israel.

Corporate Governance

InMode Ltd.’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.
Corporate governance scores courtesy of Institutional Shareholder Services (ISS) Scores indicate decile rank relative to index or region. A decile score of 1 indicates lower governance risk, while a 10 indicates higher governance risk.

Recent Events

Upcoming Events

May 02, 2024
InMode Ltd. Earnings Call

Related Tickers

TMDX TransMedics Group, Inc.
88.88
-1.90%
 
NARI Inari Medical, Inc.
38.18
+2.88%
 
DXCM DexCom, Inc.
137.87
+2.89%
 
ALGN Align Technology, Inc.
313.78
+0.61%
 
SMLR Semler Scientific, Inc.
26.62
-1.73%
 
INSP Inspire Medical Systems, Inc.
234.19
+0.11%
 
SWAV Shockwave Medical, Inc.
328.87
+0.10%
 
PACB Pacific Biosciences of California, Inc.
1.3600
-7.48%
 
ABT Abbott Laboratories
106.89
-0.65%
 
NNOX Nano-X Imaging Ltd.
9.09
-2.36%